Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)

Clinical trial NCT01019486 · COMPLETED

Trial details

NCT number: NCT01019486
Sponsor: University of Colorado, Denver
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease Type 1 Diabetes Mellitus

Start date: 2009-11-01
Primary completion: 2011-12-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.